When I encounter a newly diagnosed EGFR mutation lung cancer, especially a metastatic stage patient, usually tell them that the patient will sequentially receive different type of treatment.

It shows how adjusting eGFR results for body surface may improve decision results. The National Kidney Foundation published a consensus document that advocates transition to race-free eGFR ...